Alexa
  • Directory of Taiwan

Artificial Intelligence in Drug Discovery Market Scope and overview, 2022 Key Aspects of the Industry by Segments to 2030

The artificial intelligence (AI) in drug discovery market size is expected to reach USD 4.13 billion by 2028 according to a new study by Report Ocean. Report Ocean presents a new report on artificial intelligence (AI) in drug discovery market size, share, growth, industry trends, and forecast 2028, covering various industry elements and growth trends helpful for predicting the market’s future.

Request To Download Sample of This Strategic Report:-https://reportocean.com/industry-verticals/sample-request?report_id=BWCC158

The report “Artificial Intelligence in Drug Discovery Market – By Therapeutic Area (Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Infectious Disease, Others); By Application; By Regions; Segment Forecast – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Based on therapeutic areas, the global artificial intelligence (AI) in drug discovery market is segmented into oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious diseases, and others. In 2020, the oncology segment accounted for the largest revenue share. Artificial intelligence plays an important role in the pre-diagnosis of cancer. Cancer treatments vary from person to person and personalized medicine has played an important role.

Artificial intelligence (AI) platforms are designed to ascertain genetic mutations, helping oncologists in designing effective treatment plans. In this line, a Switzerland-based company, Sophia Genetics developed an AI platform that helps to identify tumors by detecting genetic variations and devising personalized cancer treatment plans.

However, the infectious disease segment of artificial intelligence (AI) in drug discovery industry is projected to witness a lucrative growth rate over the study period. The increasing adoption of artificial intelligence (AI) platforms in infectious diseases to identify key infection patterns. A positive scenario for the segment is also illustrated by key partnerships and collaborations in the market for artificial intelligence (AI) in drug discovery.

For instance, artificial intelligence (AI)-based drug discovery company, Existencia, entered into an agreement with Scripps Research to identify COVID-19 antiviral therapies. On the same ground, Google’s Deepmind company also working on the artificial intelligence (AI) platform AlphaFold. The product is designed to provide information on several proteins involved in the diagnosis of SARS and COVID-19.

Request To Download Sample of This Strategic Report:-
https://reportocean.com/industry-verticals/sample-request?report_id=BWCC158

Major Players:

Market participants such as IBM Watson, Alphabet (DeepMind), Exscientia, GNS Healthcare, Insitro, BioSymetrics, Euretos, Berg Health, Benevolent AI, Atomwise, and Cyclica. are some of the key players operating in the global market. The companies in the artificial intelligence (AI) industry are involved in collaborations and partnerships with artificial intelligence (AI) platform providers to revolutionize medical treatment.

In this direction, in January 2021, the U.S.-based provider of biomarkers-based therapy, Nucleai signed a collaboration agreement with Debiopharm, pharma company pioneering in drug development. According to the agreement the latter will use Nucleai’s artificial intelligence (AI) platform for its pipeline oncology drug candidates.

Artificial Intelligence in Drug Discovery, Application Outlook (Revenue – USD Million, 2016 – 2028)

Drug optimization and repurposing

Preclinical testing

Others

Artificial Intelligence in Drug Discovery, Therapeutic Area Outlook (Revenue – USD Million, 2016 – 2028)

Cardiovascular Disease

Infectious Disease

Metabolic Diseases

Neurodegenerative Diseases

Oncology

Others

Get a Sample PDF copy of the report:-https://reportocean.com/industry-verticals/sample-request?report_id=BWCC158

Artificial Intelligence in Drug Discovery, Regional Outlook (Revenue – USD Million, 2016 – 2028)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Spain

Netherlands

Austria

Asia Pacific

China

India

Japan

Malaysia

Australia

Indonesia

Central & South America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

What are the aspects of this report that relate to regional analysis?

The report’s geographical regions include North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
The report provides a comprehensive analysis of market trends, including information on usage and consumption at the regional level.
Reports on the market include the growth rates of each region, which includes their countries, over the coming years.
How are the key players in the market assessed?
This report provides a comprehensive analysis of leading competitors in the market.
The report includes information about the key vendors in the market.
The report provides a complete overview of each company, including its profile, revenue generation, cost of goods, and products manufactured.
The report presents the facts and figures about market competitors, alongside the viewpoints of leading market players.
A market report includes details on recent market developments, mergers, and acquisitions involving the key players mentioned.

Access full Report Description, TOC, Table of Figure, Chart, etc.-https://reportocean.com/industry-verticals/sample-request?report_id=BWCC158

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:
Report Ocean:
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES Tel: +1 888 212 3539 (US – TOLL FREE)
Website: https://www.reportocean.com/